Scholarlink

Aim <p>The global incidence of non-rheumatic calcific aortic valve disease (NR-CAVD) is increasing annually owing to changes in the global population structure. We aimed to comprehensively assess the global disease burden and health inequity of NR-CAVD from 1990 to 2021 and predict the situation through 2050.</p> Methods <p>Data on mortality, prevalence, incidence, DALYs, YLDs, and YLLs of NR-CAVD were extracted from the GBD 2021. The Joinpoint model, linear regression model, and health inequity index were used to evaluate the time trends from 1990 to 2021, predict the disease burden through 2050, and decompose NR-CAVD according to population aging, epidemiological changes, and population growth.</p> Results <p>From 1990 to 2021, the number of incident cases, prevalent cases, disability-adjusted life years (DALYs), and YLDs of NR-CAVD increased in both sexes, whereas the age-standardized rates are projected to decline through 2050. Decomposition analysis identified population growth as the primary driver, followed by aging. Significant health inequity in prevalence was observed across regions with different economic development levels.</p> Conclusion <p>Owing to population aging and growth, the NR-CAVD burden in middle-aged and elderly populations will continue to rise by 2050, with marked health inequity across economically divergent regions, highlighting the need to address this emerging public health challenge.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Global, regional, and national burdens of non-rheumatic calcific aortic valve disease in middle-aged and elderly populations from 1990 to 2021 and predictions up to 2050: trends, predictions, and health inequity

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月2日

查看全文
  • Jinlin Hu,
  • Teng Ge,
  • Miao Zhang,
  • Kunyang He,
  • Guanmou Li,
  • Rongjun Zou,
  • Xiaoping Fan

摘要

Aim

The global incidence of non-rheumatic calcific aortic valve disease (NR-CAVD) is increasing annually owing to changes in the global population structure. We aimed to comprehensively assess the global disease burden and health inequity of NR-CAVD from 1990 to 2021 and predict the situation through 2050.

Methods

Data on mortality, prevalence, incidence, DALYs, YLDs, and YLLs of NR-CAVD were extracted from the GBD 2021. The Joinpoint model, linear regression model, and health inequity index were used to evaluate the time trends from 1990 to 2021, predict the disease burden through 2050, and decompose NR-CAVD according to population aging, epidemiological changes, and population growth.

Results

From 1990 to 2021, the number of incident cases, prevalent cases, disability-adjusted life years (DALYs), and YLDs of NR-CAVD increased in both sexes, whereas the age-standardized rates are projected to decline through 2050. Decomposition analysis identified population growth as the primary driver, followed by aging. Significant health inequity in prevalence was observed across regions with different economic development levels.

Conclusion

Owing to population aging and growth, the NR-CAVD burden in middle-aged and elderly populations will continue to rise by 2050, with marked health inequity across economically divergent regions, highlighting the need to address this emerging public health challenge.